Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chembl4071327
Molecular Weight | 3464.0 g/mol |
---|---|
Molecular Formula | C143H244N50O42S4 |
XLogP3 | -17.2 |
Hydrogen Bond Donor Count | 55 |
Hydrogen Bond Acceptor Count | 55 |
Rotatable Bond Count | 91 |
Exact Mass | 3462.7410615 g/mol |
Monoisotopic Mass | 3461.7377067 g/mol |
Topological Polar Surface Area | 1610 Ų |
Heavy Atom Count | 239 |
Formal Charge | 0 |
Complexity | 7860 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 28 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Natrecor |
PubMed Health | Nesiritide (Injection) |
Drug Classes | Antianginal, Cardiovascular Agent |
Active Ingredient | Nesiritide recombinant |
Dosage Form | For solution |
Route | Intravenous |
Strength | 1.5mg/vial |
Market Status | Prescription |
Company | Scios |
2 of 2 | |
---|---|
Drug Name | Natrecor |
PubMed Health | Nesiritide (Injection) |
Drug Classes | Antianginal, Cardiovascular Agent |
Active Ingredient | Nesiritide recombinant |
Dosage Form | For solution |
Route | Intravenous |
Strength | 1.5mg/vial |
Market Status | Prescription |
Company | Scios |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?